Clinical Trial Update: Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal Cancer [Phase 1]

View source ↗

Summary

This update covers a Phase 1 study evaluating a nitric oxide-releasing acetylsalicylic acid (NO-ASA) for colorectal cancer prevention in individuals at high ris…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Nitric Oxide-Releasing Acetylsalicyclic Acid (nitric oxide-releasing aspirin)

Snippet

Sponsor: Stony Brook University | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED